Page last updated: 2024-08-23

isosorbide-5-mononitrate and Alcoholic Cirrhosis

isosorbide-5-mononitrate has been researched along with Alcoholic Cirrhosis in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's2 (66.67)18.2507
2000's1 (33.33)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Laleman, W; Nevens, F1
Backhouse, C; Barrientos, C; Bresky, G; Fluxá, F; Iturriaga, H; Palma, M; Ruiz, M; Silva, G1
Burroughs, AK; Chin, J; Greenslade, L; McCormick, PA; McIntyre, N; Patch, D1

Reviews

1 review(s) available for isosorbide-5-mononitrate and Alcoholic Cirrhosis

ArticleYear
Cirrhotic portal hypertension: current and future medical therapy for primary and secondary prevention of variceal bleeding.
    Minerva medica, 2006, Volume: 97, Issue:4

    Topics: Adrenergic beta-Antagonists; Animals; Contraindications; Drug Therapy, Combination; Endoscopy; Esophageal and Gastric Varices; Follow-Up Studies; Forecasting; Gastrointestinal Hemorrhage; Humans; Hypertension, Portal; Isosorbide Dinitrate; Ligation; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Middle Aged; Nadolol; Portasystemic Shunt, Surgical; Portasystemic Shunt, Transjugular Intrahepatic; Practice Guidelines as Topic; Propranolol; Randomized Controlled Trials as Topic; Rats; Risk Factors; Risk Reduction Behavior; Splanchnic Circulation; Stents; Time Factors; Vascular Resistance; Vasodilator Agents

2006

Other Studies

2 other study(ies) available for isosorbide-5-mononitrate and Alcoholic Cirrhosis

ArticleYear
[Hemodynamic and functional hepatic effects of isosorbide-5-monitrate in cirrhotic patients with portal hypertension].
    Revista medica de Chile, 1993, Volume: 121, Issue:8

    Topics: Adult; Aged; Female; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver; Liver Cirrhosis, Alcoholic; Male; Middle Aged

1993
Clinical vs haemodynamic response to drugs in portal hypertension.
    Journal of hepatology, 1998, Volume: 28, Issue:6

    Topics: Adrenergic beta-Antagonists; Blood Pressure; Esophageal and Gastric Varices; Female; Follow-Up Studies; Hemodynamics; Humans; Hypertension, Portal; Isosorbide Dinitrate; Liver Cirrhosis; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Octreotide; Propranolol; Recurrence; Sclerotherapy; Time Factors; Treatment Outcome; Vasodilator Agents

1998